Sunday, 27 September 2015

Next targeted therapy combo Cobimetinib plus Vemurafenib

Combimetinib plus Vemurafenib versus Vemurafenib alone

Copy number of BRAF not relevant for response
13% patients had additional mutations at the beginning BUT it has no effect on response.

and no surprise- combo works better than mono therapy! 

No comments:

Post a Comment